Valuing Active Life in Dementia: a trial to assess the effectiveness of community occupational therapy for people with dementia
ISRCTN | ISRCTN10748953 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN10748953 |
Secondary identifying numbers | 17304 |
- Submission date
- 18/09/2014
- Registration date
- 18/09/2014
- Last edited
- 05/01/2021
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English Summary
Background and study aims
Occupational therapists are health and social care professionals who help people to live life their way - helping people to keep up their everyday activities and remain independent for as long as possible after they develop dementia. Researchers in The Netherlands developed a Community Occupational Therapy in Dementia programme (COTiD) for people with mild to moderate dementia and their family carers. The programme showed benefits to the person with dementia in terms of their ability to carry out activities, quality of life and mood. Family carers' quality of life, mood and sense of competence also improved and the programme was cost effective. We have developed a similar programme to meet the needs of the UK population, known as COTiD- UK. The next phase is to test whether this helps people or not.
Who can participate?
People with mild to moderate dementia who have a family carer willing to participate may be involved in the study. Participants need to be over the age of 18.
What does the study involve?
Participants will be randomly allocated to receive either the COTiD-UK intervention (ten 1-hour occupational therapy sessions delivered in the person with dementia's home), or to continue with their usual care. Outcome measures will be completed at the start, then at 12, 26 and 52 weeks, with the first half of the participants also completing a 78-week follow-up.
What are the possible benefits and risks of participating?
COTiD-UK offers more intensive occupational therapy input at an earlier stage than is currently provided in the UK, which has potential benefits to the participants. Participants may find talking about the experience of having dementia or caring for a person with dementia upsetting. Research staff will be trained and experienced in conducting interviews of this nature and to respond sensitively and appropriately. Participants may reveal circumstances that have or may place them at risk of harm or neglect. Research staff will be trained to recognise these risks and where appropriate to take action.
Where is the study run from?
This study has been set up in North East London NHS Foundation Trust, UK. There are two other research centres in Sheffield and Hull (UK).
When is the study starting and how long is it expected to run for?
September 2014 to September 2017.
Who is funding the study?
National Institute for Health Research (NIHR) (UK).
Who is the main contact?
Dr Jennifer Wenborn
j.wenborn@ucl.ac.uk
Contact information
Scientific
R&D Department
1st Floor Maggie Lilley Suite
Goodmayes Hospital
157 Barley Lane
Ilford
IG3 8XJ
United Kingdom
j.wenborn@ucl.ac.uk |
Study information
Study design | Randomised; Interventional and Observational; Design type: Treatment, Qualitative |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Valuing Active Life in Dementia (VALID) Work Packages 3/4: a pilot trial and randomised controlled trial of Community Occupational Therapy in Dementia (COTiD-UK) |
Study acronym | VALID |
Study hypothesis | It is hypothesised that in comparison to 'treatment as usual', COTiD-UK will: 1. Significantly improve ADL abilities in people with dementia 2. Significantly improve quality of life of the people with dementia and their family carers 3. Demonstrate cost effectiveness |
Ethics approval(s) | NRES Committee London - Camberwell St Giles, 14/07/2014 (minor amendment approved: 25/07/2014), ref: 14/LO/0736 |
Condition | Topic: Dementias and neurodegeneration; Subtopic: Dementia; Disease: Dementia |
Intervention | In total, 480 dyads (a person with dementia and their family carer) will be recruited and randomly allocated to EITHER receive the COTiD-UK intervention (ten 1-hour occupational therapy sessions delivered in the person with dementia's home) OR to continue with their usual care (TAU). Qualitative data will also be collected through interviews and observation of COTiD-UK sessions. |
Intervention type | Other |
Primary outcome measure | Activities of Daily Living Scale - Bristol Activities of Daily Living Scale. Outcome measures will be completed at baseline, then at: 12, 26 and 52 weeks, with the first 40% of the participants also completing a 78-week follow-up |
Secondary outcome measures | 1. Canadian Occupational Performance Measure (COPM) 2. Client Service Receipt Inventory (CSRI) 3. Mini Mental State Examination (MMSE) 4. Interview of Deterioration in Daily activities in Dementia (IDDD) 5. Dementia Quality of Life Scale (DEMQOL) 6. European Quality of Life - Five Dimensions (EQ-5D) 5 Level 7. Cornell Scale for Depression in Dementia (CSDD) 8. Serious adverse events 9. Use of psychotropic drugs 10. Sense of Competence Questionnaire (SCQ) 11. Hospital Anxiety and Depression Scale (HADS) |
Overall study start date | 01/09/2014 |
Overall study end date | 30/06/2018 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | Planned Sample Size: 985; UK Sample Size: 985 |
Total final enrolment | 936 |
Participant inclusion criteria | Inclusion criteria for people with dementia: 1. Living in the community in own home (includes sheltered accommodation) 2. Identified family carer who provides at least four hours support per week 3. Has a diagnosis of dementia, as defined by the DSM-IV and scores between 0.5 and 2 on the Clinical Dementia Rating Scale 4. Able to converse in English 5. Able and willing to participate in the COTiD-UK intervention in partnership with their family carer, i.e., ten 1-hour sessions of home-based occupational therapy 6. Has capacity to provide his/her consent Inclusion criteria for family caregivers: 1. Aged 18 or over 2. Is currently providing practical support with domestic and/or personal activities to the person with dementia for a minimum of 4 hours per week 3. Able to converse in English 4. Able and willing to participate in the COTiD-UK intervention in partnership with the person with dementia that they support, i.e., ten 1-hour sessions of home-based occupational therapy 5. Has capacity to provide his/her consent Inclusion criteria for occupational therapist participants: 1. Be registered as an occupational therapist with the Health and Care Professions Council 2. Have experience of working in the community and/or with people who have dementia and their family carers 3. Have completed the COTi-DUK training and achieved fidelity with COTi-DUK implementation |
Participant exclusion criteria | Exclusion criteria for people with dementia: 1. Participating in another intervention research study 2. Currently in hospital or living in a care home Exclusion criteria for family carers: 1. Participating in another intervention research study |
Recruitment start date | 01/09/2014 |
Recruitment end date | 30/06/2017 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
IG3 8XJ
United Kingdom
Sponsor information
Hospital/treatment centre
R&D Department
1st Floor Maggie Lilley Suite
Goodmayes Hospital
157 Barley Lane
Ilford
IG3 8XJ
England
United Kingdom
"ROR" | https://ror.org/023e5m798 |
---|
Funders
Funder type
Government
Government organisation / National government
- Alternative name(s)
- National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
- Location
- United Kingdom
Results and Publications
Intention to publish date | 30/06/2020 |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 03/02/2016 | Yes | No | |
Results article | results | 04/01/2021 | 05/01/2021 | Yes | No |
HRA research summary | 28/06/2023 | No | No |
Editorial Notes
05/01/2021: Publication reference added.
13/09/2019: The following changes have been made:
1. The final enrolment number has been added.
2. An intention to publish date has been added.
28/09/2016: The recruitment end date was changed from 31/03/2016 to 30/06/2017
27/09/2016: The overall end date was changed from 30/09/2017 to 30/06/2018
05/02/2016: Publication reference added.
On 08/10/2015 the overall trial end date was changed from 31/07/2015 to 30/09/2017.